Literature DB >> 3589148

Inhibition of rat brain monoamine oxidase and succinic dehydrogenase by anticonvulsant pyrazolines.

N Soni, K Pande, R Kalsi, T K Gupta, S S Parmar, J P Barthwal.   

Abstract

Substituted 1,5-diaryl-3(4-chlorophenyl)-delta 2-pyrazolines were synthesized and evaluated for anticonvulsant activity. Most pyrazolines (100 mg/kg) provided 20-80% protection against pentylenetetrazol-induced convulsions in mice. All compounds inhibited rat brain mitochondrial monoamine oxidase (MAO) and succinic dehydrogenase (SDH) and exhibited low toxicity as reflected by approximate LD50 values (500 to greater than 1000 mg/kg) in mice.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3589148

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN: 0034-5164


  5 in total

1.  A novel pseudo six-component synthesis of functionalized pyrazoles in ethanol by cascade reaction.

Authors:  Atieh Rezvanian; Maedeh Babashah; Maryam Anafcheh
Journal:  Mol Divers       Date:  2019-01-11       Impact factor: 2.943

2.  Eco-friendly synthesis and antimicrobial activities of some 1-phenyl-3(5-bromothiophen-2-yl)-5-(substituted phenyl)-2-pyrazolines.

Authors:  Ramalingam Sasikala; Kannan Thirumurthy; Perumal Mayavel; Ganesamoorthy Thirunarayanan
Journal:  Org Med Chem Lett       Date:  2012-06-11

3.  1-[5-(Anthracen-9-yl)-3-phenyl-4,5-dihydro-1H-pyrazol-1-yl]ethanone.

Authors:  Ming-Liang Wang; Bao-Li Dong; Yong-Hua Li
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-12-11

4.  An improved synthesis of 1,3,5-triaryl-2-pyrazolines in acetic acid aqueous solution under ultrasound irradiation.

Authors:  Ji-Tai Li; Xiao-Hui Zhang; Zhi-Ping Lin
Journal:  Beilstein J Org Chem       Date:  2007-03-21       Impact factor: 2.883

5.  Synthesis and in vitro antimicrobial activity of some pyrazolyl-1-carboxamide derivatives.

Authors:  Essam Mohamed Sharshira; Nagwa Mohamed Mahrous Hamada
Journal:  Molecules       Date:  2011-09-09       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.